Follow-on glatiramer acetate

eNeurologicalSci. 2018 Nov 23:13:51-52. doi: 10.1016/j.ensci.2018.11.019. eCollection 2018 Dec.

¹ Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.
² Lycalis sprl, Brussels, Belgium.
³ Neurology Center, Łódź, Poland.
⁴ Synthon BV, Nijmegen, The Netherlands.

No abstract available

Keywords: Biosimilars; Generics; Glatiramer acetate; Multiple sclerosis; Non-biological complex drugs.